Spears Abacus Advisors LLC Novartis Ag Transaction History
Spears Abacus Advisors LLC
- $4.34 Billion
- Q4 2024
A detailed history of Spears Abacus Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 5,545 shares of NVS stock, worth $618,156. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,545
Previous 5,878
5.67%
Holding current value
$618,156
Previous $676,000
20.27%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,486Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$912 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$766 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$622 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $240B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...